Carlos Manuel Buesa Arjol
Vorstandsvorsitzender bei ORYZON GENOMICS S.A.
Vermögen: 7 Mio $ am 30.04.2024
Aktive Positionen von Carlos Manuel Buesa Arjol
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ORYZON GENOMICS S.A. | Vorstandsvorsitzender | 02.06.2000 | - |
Vorsitzender | 02.06.2000 | - | |
Gründer | 02.06.2000 | - | |
Präsident | 02.06.2000 | - | |
Asociacion De Empresas Biotecnologicas
Asociacion De Empresas Biotecnologicas BiotechnologyHealth Technology Asociacion De Empresas Biotecnologicas operates as a Spanish biotechnology company. The private company is based in Madrid, Spain. | Direktor/Vorstandsmitglied | - | - |
Oncnosis Pharma AIE | Direktor/Vorstandsmitglied | - | - |
Orycamb Project Aie
Orycamb Project Aie Construction MaterialsNon-Energy Minerals Orycamb Project Aie is a Spanish company that engages in the mining of gravel and sandpits. The private company is based in Tarragona, Spain. | Direktor/Vorstandsmitglied | - | - |
Ninfas Aie | Direktor/Vorstandsmitglied | - | - |
Geadig-Pharma Aie | Direktor/Vorstandsmitglied | - | - |
Mendelion Lifesciences SL
Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Mendelion Lifesciences SL constructs commercial buildings. | Corporate Officer/Principal | - | - |
Karriereverlauf von Carlos Manuel Buesa Arjol
Ehemalige bekannte Positionen von Carlos Manuel Buesa Arjol
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Inveready Seed Capital SCR SA
Inveready Seed Capital SCR SA Investment ManagersFinance Inveready Seed Capital SCR SA fund invests in the early years of technology-oriented companies. Specifically, this fund focuses on the seed stage. The fund will invest between €100,000 and €500,000 for a minority stake in the invested company. | Direktor/Vorstandsmitglied | 07.09.2008 | 01.06.2021 |
Neurotec Pharma SL
Neurotec Pharma SL BiotechnologyHealth Technology Neurotec Pharma SL is a holding company engaged in the development and manufacture of pharmaceutical products. It develops diagnostic and therapeutics tools for acute and chronic central nervous system diseases, such as Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer's Disease It also provides biomedical research and clinical testing services. The company was founded by Nicole Mahy, Manuel Rodriguez, and Marco Pugliese on January 4, 2006, and is headquartered in Barcelona, Spain. | Direktor/Vorstandsmitglied | - | 27.11.2015 |
░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░░░ | ░░░░░░░░░ | - | - |
░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Carlos Manuel Buesa Arjol
University of Barcelona | Doctorate Degree |
Statistik
International
Spanien | 13 |
Operativ
Director/Board Member | 8 |
President | 2 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ORYZON GENOMICS S.A. | Health Technology |
Private Unternehmen | 10 |
---|---|
Inveready Seed Capital SCR SA
Inveready Seed Capital SCR SA Investment ManagersFinance Inveready Seed Capital SCR SA fund invests in the early years of technology-oriented companies. Specifically, this fund focuses on the seed stage. The fund will invest between €100,000 and €500,000 for a minority stake in the invested company. | Finance |
Palobiofarma SL
Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | Health Technology |
Neurotec Pharma SL
Neurotec Pharma SL BiotechnologyHealth Technology Neurotec Pharma SL is a holding company engaged in the development and manufacture of pharmaceutical products. It develops diagnostic and therapeutics tools for acute and chronic central nervous system diseases, such as Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer's Disease It also provides biomedical research and clinical testing services. The company was founded by Nicole Mahy, Manuel Rodriguez, and Marco Pugliese on January 4, 2006, and is headquartered in Barcelona, Spain. | Health Technology |
Oncnosis Pharma AIE | |
l'Associació Catalana d'Empreses de Biotecnologia
l'Associació Catalana d'Empreses de Biotecnologia Miscellaneous Commercial ServicesCommercial Services l'Associació Catalana d'Empreses de Biotecnologia is business association operating company. It is engaged in promoting health and life sciences activities for biotechnology organizations, business leaders, senior executives, entrepreneurs, investors and journalists. The company was founded in 2006 and is headquartered in Barcelona, Spain. | Commercial Services |
Orycamb Project Aie
Orycamb Project Aie Construction MaterialsNon-Energy Minerals Orycamb Project Aie is a Spanish company that engages in the mining of gravel and sandpits. The private company is based in Tarragona, Spain. | Non-Energy Minerals |
Mendelion Lifesciences SL
Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Mendelion Lifesciences SL constructs commercial buildings. | Industrial Services |
Asociacion De Empresas Biotecnologicas
Asociacion De Empresas Biotecnologicas BiotechnologyHealth Technology Asociacion De Empresas Biotecnologicas operates as a Spanish biotechnology company. The private company is based in Madrid, Spain. | Health Technology |
Ninfas Aie | |
Geadig-Pharma Aie |